Taipei Exchange - Delayed Quote TWD

BiOptic Inc. (6850.TWO)

Compare
41.15
+0.45
+(1.11%)
At close: 12:54:11 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
228,269.00
228,269.00
231,404.00
179,283.00
123,625.00
Cost of Revenue
75,524.00
75,524.00
78,758.00
68,905.00
44,455.00
Gross Profit
152,745.00
152,745.00
152,646.00
110,378.00
79,170.00
Operating Expense
108,333.00
108,333.00
87,641.00
65,928.00
52,201.00
Operating Income
44,412.00
44,412.00
65,005.00
44,450.00
26,969.00
Net Non Operating Interest Income Expense
1,329.00
1,329.00
967.00
-307.00
-794.00
Pretax Income
48,403.00
48,403.00
78,307.00
49,675.00
26,383.00
Tax Provision
8,281.00
8,281.00
14,952.00
1,056.00
-194.00
Net Income Common Stockholders
37,747.00
37,747.00
61,272.00
46,251.00
25,933.00
Diluted NI Available to Com Stockholders
37,747.00
37,747.00
61,272.00
46,251.00
25,933.00
Basic EPS
1.42
--
2.30
1.84
1.32
Diluted EPS
1.41
--
2.29
1.84
1.31
Basic Average Shares
26,620.00
--
26,620.00
25,128.40
19,647.98
Diluted Average Shares
26,733.00
--
26,771.00
25,204.30
19,922.65
Total Expenses
183,857.00
183,857.00
166,399.00
134,833.00
96,656.00
Net Income from Continuing & Discontinued Operation
37,747.00
37,747.00
61,272.00
46,251.00
25,933.00
Normalized Income
38,044.58
38,044.58
61,332.68
46,537.77
26,001.80
Interest Income
2,673.00
2,673.00
1,253.00
302.00
228.00
Interest Expense
1,344.00
1,344.00
286.00
609.00
1,022.00
Net Interest Income
1,329.00
1,329.00
967.00
-307.00
-794.00
EBIT
49,747.00
49,747.00
78,593.00
50,284.00
27,405.00
EBITDA
65,038.00
65,038.00
88,914.00
57,376.00
32,091.00
Reconciled Cost of Revenue
75,524.00
75,524.00
78,758.00
68,905.00
44,455.00
Reconciled Depreciation
15,291.00
15,291.00
10,321.00
7,092.00
4,686.00
Net Income from Continuing Operation Net Minority Interest
37,747.00
37,747.00
61,272.00
46,251.00
25,933.00
Total Unusual Items Excluding Goodwill
-359.00
-359.00
-75.00
-293.00
-86.00
Total Unusual Items
-359.00
-359.00
-75.00
-293.00
-86.00
Normalized EBITDA
65,397.00
65,397.00
88,989.00
57,669.00
32,177.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-61.42
-61.42
-14.32
-6.23
-17.20
12/31/2020 - 11/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

7790.TWO SSLab
72.00
+0.28%
 
7754.TWO AnnJi
32.55
-3.70%
 
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
 
6999.TWO Han Biomedical
34.90
+0.58%
 
7776.TWO Anya
37.90
+5.72%
 
6879.TWO TCI GENE Inc.
52.00
0.00%
 
7725.TWO LabTurbo Biotech Corporation
24.00
0.00%
 
6634.TWO Sinew Pharma Inc.
49.45
-0.40%
 
6848.TWO RBC Bioscience Corporation
19.05
0.00%
 
6814.TWO Lukas Biomedical Inc.
27.60
0.00%